Edition:
India

Applied DNA Sciences Inc (APDN.OQ)

APDN.OQ on NASDAQ Stock Exchange Capital Market

0.21USD
14 Oct 2019
Change (% chg)

$0.01 (+3.33%)
Prev Close
$0.20
Open
$0.22
Day's High
$0.22
Day's Low
$0.21
Volume
43,965
Avg. Vol
84,806
52-wk High
$1.55
52-wk Low
$0.20

Latest Key Developments (Source: Significant Developments)

Applied DNA Sciences Announces Q3 Loss Per Share $0.04
Wednesday, 14 Aug 2019 

Aug 13 (Reuters) - Applied DNA Sciences Inc ::APPLIED DNA REPORTS FISCAL THIRD QUARTER 2019 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.04.Q3 REVENUE $2.1 MILLION.  Full Article

Applied DNA Signs Master Services Agreement With Schreiner Group To Deliver Signature DNA Labels To Protect Pharmaceutical Supply Chains
Wednesday, 7 Aug 2019 

Aug 7 (Reuters) - Applied DNA Sciences Inc ::APPLIED DNA SIGNS MASTER SERVICES AGREEMENT WITH SCHREINER GROUP TO DELIVER SIGNATURE® DNA LABELS TO PROTECT PHARMACEUTICAL SUPPLY CHAINS.APPLIED DNA SCIENCES INC - SIGNING OF A MASTER SERVICES AGREEMENT WITH GERMANY-BASED SCHREINER GROUP.APPLIED DNA SCIENCES - WILL SUPPLY ITS SIGNATURE DNA FORENSIC MOLECULAR TAG WITH BEACON SCREENING FEATURE FOR SCHREINER MEDIPHARM'S SECURITY PORTFOLIO.  Full Article

Applied DNA Sciences Says Q2 Revenue Fell 25 Percent To $778,000
Friday, 10 May 2019 

May 9 (Reuters) - Applied DNA Sciences Inc ::APPLIED DNA REPORTS FISCAL SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.08.Q2 REVENUE FELL 25 PERCENT TO $778,000.  Full Article

Applied Dna And Eurofins BLC Sing Pact To Support Commercial Implementation Of Leather Traceability System
Monday, 19 Nov 2018 

Nov 19 (Reuters) - Applied DNA Sciences Inc ::APPLIED DNA AND EUROFINS BLC SIGN COLLABORATION AGREEMENT TO SUPPORT COMMERCIAL IMPLEMENTATION OF LEATHER TRACEABILITY SYSTEM.APPLIED DNA SCIENCES INC - SIGNING OF AGREEMENT FOLLOWS SUCCESSFUL COMPLETION OF FUNDED CONSORTIUM RESEARCH PROJECT WITH BLC AS ANNOUNCED IN MAY 2018.  Full Article

Applied DNA Forms Subsidiary, Linearx
Tuesday, 18 Sep 2018 

Sept 18 (Reuters) - Applied DNA Sciences Inc ::APPLIED DNA FORMS WHOLLY OWNED SUBSIDIARY, LINEARX, TO DEVELOP LARGE-SCALE, PCR-PRODUCED DNA FOR BIOTHERAPEUTICS.APPLIED DNA SCIENCES - PURPOSE OF NEW UNIT TO COMMERCIALIZE CO'S DESIGN, MANUFACTURE AND CHEMICAL MODIFICATION OF DNA.APPLIED DNA - LINEARX WILL ALSO SUBSUME CURRENT ACTIVITIES OF CO AS A CRO AND CMO TO BIOTHERAPEUTICS MARKET.  Full Article

Applied DNA Signs Agreements With Colorcon For Molecular Tagging In Pharmaceutical, Nutraceutical Markets
Thursday, 5 Apr 2018 

April 5 (Reuters) - Applied DNA Sciences Inc ::APPLIED DNA SIGNS DEFINITIVE AGREEMENTS WITH COLORCON FOR MOLECULAR TAGGING IN THE PHARMACEUTICAL AND NUTRACEUTICAL MARKETS.AGREEMENTS INCLUDES MILESTONE PAYMENTS. LONG-TERM LICENSING ROYALTIES TO BE PAID TO APPLIED DNA FOLLOWING SALES..‍FIRST OF TWO MILESTONE PAYMENTS IS PAYABLE TO APPLIED DNA WITH SIGNING OF AGREEMENTS​.‍TO GET SECOND MILESTONE PAYMENT ON INITIAL APPROVAL BY REGULATORY AUTHORITY FOR APPLICATION IN SOD PHARMACEUTICAL OR NUTRACEUTICAL PRODUCT APPLICATION.WILL SUPPLY TAGGANT AND AUTHENTICATION MATERIALS TO COLORCON IN EXCHANGE FOR LONG-TERM ROYALTIES.AGREEMENTS GENERALLY EXPIRE ON LATER OF OCTOBER 1, 2032 OR LAST EXPIRATION DATE OF ANY PATENT LICENSED UNDER AGREEMENT​.  Full Article

Applied DNA Reports Q1 Loss Per Share $0.12
Friday, 9 Feb 2018 

Feb 8 (Reuters) - Applied Dna Sciences Inc ::APPLIED DNA REPORTS FISCAL FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.12.Q1 REVENUE FELL 28 PERCENT TO $648,000.SEES FY 2018 REVENUE $6.5 MILLION.  Full Article

Double Medical Technology unit obtains high-tech enterprise recognition
Thursday, 8 Feb 2018 

Feb 8(Reuters) - Double Medical Technology Inc <002901.SZ> ::Says its unit recognized as high-tech enterprise .Says its unit will enjoy tax preference of 15 percent for three years from Dec. 1, 2017 .  Full Article

Applied DNA Sciences Establishes New Central DNA Testing Laboratory In India
Tuesday, 23 Jan 2018 

Jan 23 (Reuters) - Applied Dna Sciences Inc ::APPLIED DNA SCIENCES INC SAYS HAS ESTABLISHED A CENTRAL DNA TESTING LABORATORY IN AHMEDABAD, INDIA, PROVIDING FULL FORENSIC AUTHENTICATION SERVICES.  Full Article

Wuhan Thalys Medical Technology and partner jointly sign contract with Pingdu People's Hospital
Monday, 8 Jan 2018 

Jan 8(Reuters) - Wuhan Thalys Medical Technology Inc <603716.SS>:Says it and China Resources Shandong Pharmaceutical Co Ltd jointly signed contract with Pingdu People's Hospital, regarding centralized purchasing and supply of test reagent and consumable.  Full Article